Be able to maintain patients on buprenorphine, and deal with special situations in buprenorphine treatment.
Goal: The learner will be able to maintain patients on buprenorphine, and deal with special situations in buprenorphine treatment including continued use of drugs during buprenorphine treatment, discontinuation of buprenorphine treatment, and the use of buprenorphine in medically supervised withdrawal from opioids (detoxification).
Demonstrate a thorough understanding of dosing principles to help your patients succeed throughout the maintenance phase of buprenorphine treatment.
Recognize and anticipate complications of buprenorphine use during the maintenance phase of treatment and prepare to deal with and minimize complications in your patients when discontinuing buprenorphine or using buprenorphine in medically supervised withdrawal (detoxification).
Prepare to deal with and minimize complications in your patients when discontinuing buprenorphine or using buprenorphine in medically supervised withdrawal (detoxification).
Demonstrate a thorough understanding of special situations in buprenorphine treatment: continued use of drugs while on buprenorphine, tapering off of buprenorphine, and use of buprenorphine for medically supervised withdrawal from opioids (detoxification).
Understand the regulations and requirements of office-based buprenorphine treatment.
Goal: The learner will understand the changing role of addiction treatment in primary care, including recent legislative changes that permit office-based treatment of opioid use disorder as well as rules and regulations for conducting such a practice.
Discuss changes in treatment options and physician's role in addiction treatment provided by the DATA 2000 amendment to the Controlled Substances Act and integrate these changes in their own patient care practices
Explain the requirements and process of becoming certified to prescribe buprenorphine for opioid use disorder
Describe basic elements in an office-based buprenorphine practice
Discuss the pertinence of confidentiality regulations (and exceptions) to substance use disorder treatment and OBOT specifically and implement these rules in clinical practice.
Describe the requirements for medical recordkeeping in OBOT practices
Describe how to set up a practice and work with health insurance companies or patients to bill for buprenorphine treatment
Be able to safely initiate and maintain special populations on buprenorphine.
Goal: The learner will be able to safely transfer methadone patients to buprenorphine maintenance and induct and maintain other special populations on buprenorphine.
Demonstrate an understanding of special precautions required throughout the phases of buprenorphine treatment for patients on methadone and other special populations, including pregnant women, teens, elderly, patients with psychiatric comorbidities, and patients with chronic pain.
Recognize and anticipate complications of buprenorphine use and prepare to deal with occasional complications in methadone patients and other special populations
Then you can submit your waiver request to CSAT/SAMHSA.
When all the modules are completed, return to the Steps Page to complete the final assessments and request/ print your certificates.
Development of this website was funded entirely by grant #R44DA12066 and contract #HHSN271200655304C from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. The website contents are solely the responsibility of the authors and do not necessarily represent the official views of NIDA. Ongoing development and maintenance is funded by the training fee and Clinical Tools, Inc. No commercial support is received.
Clinical Tools, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
Interactive training is delivered by the CTI Learning Ecosystem and our FAOS DLearning Drupal modules and requires IE 10/ higher, Firefox, Chrome or Safari.
Unless otherwise noted, individuals pictured are models and are used for illustrative purposes only.
developed & maintained by
A member of The Clinical Tools, Inc (CTI) Addiction Training Group: SBIRT Training | Opioid Risk Reduction | Buprenorphine Training
This site is for educational purposes only and medical decisions should not be based solely on its content. This site, its authors, and its consultants do not assume liability for errors or omissions.